206 related articles for article (PubMed ID: 24820971)
1. S100A8 contributes to drug resistance by promoting autophagy in leukemia cells.
Yang M; Zeng P; Kang R; Yu Y; Yang L; Tang D; Cao L
PLoS One; 2014; 9(5):e97242. PubMed ID: 24820971
[TBL] [Abstract][Full Text] [Related]
2. S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid leukemia cell death by down-regulating autophagy.
Yang L; Yang M; Zhang H; Wang Z; Yu Y; Xie M; Zhao M; Liu L; Cao L
Int J Mol Med; 2012 Jan; 29(1):65-72. PubMed ID: 21971985
[TBL] [Abstract][Full Text] [Related]
3. S100A8 promotes chemoresistance via augmenting autophagy in B‑cell lymphoma cells.
Zhang L; Zhou S; Zhou T; Yuan K; Li X; Tang J
Oncol Rep; 2021 Jan; 45(1):151-158. PubMed ID: 33169801
[TBL] [Abstract][Full Text] [Related]
4. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells.
Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A
Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223
[TBL] [Abstract][Full Text] [Related]
5. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3.
Ghavami S; Eshragi M; Ande SR; Chazin WJ; Klonisch T; Halayko AJ; McNeill KD; Hashemi M; Kerkhoff C; Los M
Cell Res; 2010 Mar; 20(3):314-31. PubMed ID: 19935772
[TBL] [Abstract][Full Text] [Related]
6. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
7. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival.
Kang R; Tang D; Schapiro NE; Livesey KM; Farkas A; Loughran P; Bierhaus A; Lotze MT; Zeh HJ
Cell Death Differ; 2010 Apr; 17(4):666-76. PubMed ID: 19834494
[TBL] [Abstract][Full Text] [Related]
8. S100A8 and S100A9 promote endothelial cell activation through the RAGE‑mediated mammalian target of rapamycin complex 2 pathway.
Zhong X; Xie F; Chen L; Liu Z; Wang Q
Mol Med Rep; 2020 Dec; 22(6):5293-5303. PubMed ID: 33174028
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 promotes drug resistance in osteosarcoma.
Huang J; Ni J; Liu K; Yu Y; Xie M; Kang R; Vernon P; Cao L; Tang D
Cancer Res; 2012 Jan; 72(1):230-8. PubMed ID: 22102692
[TBL] [Abstract][Full Text] [Related]
10. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
11. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat.
Taccioli C; Wan SG; Liu CG; Alder H; Volinia S; Farber JL; Croce CM; Fong LY
Gastroenterology; 2009 Mar; 136(3):953-66. PubMed ID: 19111725
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of WAVE1 enhances apoptosis of leukemia cells by downregulating autophagy.
Zhang Z; Wu B; Chai W; Cao L; Wang Y; Yu Y; Yang L
Int J Oncol; 2016 Jun; 48(6):2647-56. PubMed ID: 27035872
[TBL] [Abstract][Full Text] [Related]
13. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
14. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.
Zhang SF; Wang XY; Fu ZQ; Peng QH; Zhang JY; Ye F; Fu YF; Zhou CY; Lu WG; Cheng XD; Xie X
Autophagy; 2015; 11(2):225-38. PubMed ID: 25607466
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
Zheng B; Zhu H; Gu D; Pan X; Qian L; Xue B; Yang D; Zhou J; Shan Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):234-239. PubMed ID: 25712526
[TBL] [Abstract][Full Text] [Related]
16. A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy.
He W; Wang Q; Srinivasan B; Xu J; Padilla MT; Li Z; Wang X; Liu Y; Gou X; Shen HM; Xing C; Lin Y
Oncogene; 2014 Jun; 33(23):3004-13. PubMed ID: 23831571
[TBL] [Abstract][Full Text] [Related]
17. Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells.
Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
Autophagy; 2017 Apr; 13(4):761-762. PubMed ID: 28118076
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy.
Cheng J; Wei HL; Chen J; Xie B
Toxicol Mech Methods; 2012 Sep; 22(7):512-9. PubMed ID: 22519831
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells.
Yang L; Yu Y; Kang R; Yang M; Xie M; Wang Z; Tang D; Zhao M; Liu L; Zhang H; Cao L
Leuk Lymphoma; 2012 Feb; 53(2):315-22. PubMed ID: 21864037
[TBL] [Abstract][Full Text] [Related]
20. Cleaving Beclin 1 to suppress autophagy in chemotherapy-induced apoptosis.
Li H; Wang P; Yu J; Zhang L
Autophagy; 2011 Oct; 7(10):1239-41. PubMed ID: 21610315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
